Warner-Lambert still in Swiss-type pain in the UK
Following the guidance from the Court of Appeal, Mr Justice Arnold has ruled that some of the claims of Warner-Lambert's second medical use patent for the drug pregabalin are invalid, and that Actavis has not infringed two claims directed to the use of pregabalin
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
